CC-92328

· Celgene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CC-92328, covering 2025-03-24 to 2025-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 1]

See pricing